* Clover Health Investments Corp CLOV.OQ CLOV.O is
expected
to show a rise in quarterly revenue when it reports results on
August 8.
* The Franklin Tennessee-based company is expected to
report a
97.5% increase in revenue to $814.616 million from $412.47
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Clover Health
Investments
Corp is for a loss of 21 cents per share. For the same quarter
last year, the company reported a loss of 78 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clover
Health
Investments Corp is $3, below its last closing price of $3.26.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 -0.28 -0.27 -0.19 Beat 30.5
Dec. 31 2022 -0.27 -0.26 -0.28 Missed -7.9
Sep. 30 2021 -0.24 -0.23 -0.08 Beat 65
Jun. 30 2021 -0.13 -0.14 -0.78 Missed -476.4
Mar. -0.11 -0.11 -0.13 Missed -17.5
31 2021
Dec. 31 2020 -0.84
This summary was machine generated August 6 at 02:10 GMT. All
figures in US dollars unless otherwise stated